Efficacy of IsaPomDex triplet therapy in double refractory multiple myeloma patients in real clinical practice in Russia

Background. Data from real-life clinical practice studies provide additional information on the efficacy of new antitumor therapy regimens, including in patients who meet exclusion criteria for clinical trials.Aim. To evaluate the Isaomex triplet efficacy in multiple myeloma patients in real clinica...

Full description

Saved in:
Bibliographic Details
Main Authors: M. V. Solovev, M. V. Solovevа, L. P. Mendeleeva, T. I. Pospelova, N. V. Skvortsova, S. V. Voloshin, A. D. Garifullin, A. S. Chuprakova, T. A. Mitina, I. S. Usankin, I. V. Vasileva, N. V. Medvedeva, V. V. Ryabchikova, M. Ya. Kiseleva, G. A. Dudina, Yu. S. Gammershmidt, O. S. Kuznetsova, Yu. V. Dolgushina, G. B. Kuchma, T. N. Tsyganok, E. N. Misyurina, E. I. Zhelnova, A. V. Kopylova, M. N. Zakharova, A. V. Korobkin, G. S. Tumyan, A. A. Semenova, E. G. Kirillova, E. M. Volodicheva, V. I. Bakhtina, T. I. Olkhovik, N. R. Solovkova, M. V. Demchenkova, O. E. Ochirova, O. L. Panteleeva, V. S. Abramova
Format: Article
Language:Russian
Published: ABV-press 2024-12-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/979
Tags: Add Tag
No Tags, Be the first to tag this record!